经导管主动脉瓣植入术患者的种族间差异
该多国注册队列研究比较了在美国两个中心和韩国一个中心接受TAVI的严重主动脉瓣狭窄患者中亚洲与非亚洲人群的基线特征和临床结局。共纳入1412例患者(亚洲581例,非亚洲831例),亚洲组1年主要复合终点(死亡、卒中或再住院)未校正风险显著更低,但多因素校正后差异无统计学意义,提示结局差异主要由基线临床、解剖和手术因素解释。
要点
- 亚洲与非亚洲TAVI患者基线特征存在显著差异。
- 未校正时亚洲组1年主要复合终点和全因死亡更低。
- 多因素校正后种族间临床结局风险无显著差异。
核心结论
- 亚洲与非亚洲TAVI患者基线及手术因素存在显著差异,观察到的结局差异主要由这些基线差异解释。
研究设计与样本
- 注册-based、多国队列研究,纳入美国和韩国三个中心接受TAVI的严重主动脉瓣狭窄患者1412例(亚洲581例,非亚洲831例)。
主要发现
- 1年主要复合终点(死亡、卒中或再住院)亚洲组26.0% vs 非亚洲组35.0%,HR 0.73(95%CI 0.59-0.89),p=0.003。
- 校正基线协变量后,主要复合终点风险无显著差异(HR 0.79;95%CI 0.60-1.03;p=0.08)。
- 1年全因死亡亚洲组7.4% vs 非亚洲组12.5%,HR 0.60(95%CI 0.41-0.88),p=0.009;多变量校正后无显著差异(HR 1.17;95%CI 0.73-1.88;p=0.52)。
临床怎么用
- 临床评估TAVI预后时应充分考虑种族间基线临床、解剖和手术因素的差异,而非仅依据种族本身。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Little information exists about inter-racial differences in patients with aortic stenosis (AS) undergoing transcatheter aortic valve implantation (TAVI). We investigated whether differences in baseline characteristics between Asian and non-Asian population may contribute to disparities in clinical outcomes after TAVI. METHODS: We performed a registry-based, multinational cohort study of patients with severe AS who underwent TAVI at two centres in the USA and one centre in South Korea. The primary outcome was a composite of death, stroke or rehospitalisation at 1 year. RESULTS: Of 1412 patients, 581 patients were Asian and 831 were non-Asian (87.5% white, 1.7% black, 6.1% Hispanic or 4.7% others). There were substantial differences in baseline characteristics between two racial groups. The primary composite outcome was significantly lower in the Asian group than in the non-Asian group (26.0% vs 35.0%; HR 0.73; 95% CI 0.59 to 0.89; p=0.003). However, after adjustment of baseline covariates, the risk of primary composite outcome was not significantly different (HR 0.79; 95% CI 0.60 to 1.03; p=0.08). The all-cause mortality at 1 year was significantly lower in the Asian group than the non-Asian group (7.4% vs 12.5%; HR 0.60; 95% CI 0.41 to 0.88; p=0.009). After multivariable adjustment, the risk of all-cause mortality was also similar (HR 1.17; 95% CI 0.73 to 1.88; p=0.52). CONCLUSIONS: There were significant differences in baseline and procedural factors among Asian and non-Asian patients who underwent TAVI. Observed inter-racial differences in clinical outcomes were largely explained by baseline differences in clinical, anatomical and procedural factors. TRIAL REGISTRATION NUMBER: NCT03826264 (https://wwwclinicaltrialsgov).
引用
- Kang DY, Ahn JM, Kim JB, et al. Inter-racial differences in patients undergoing transcatheter aortic valve implantation. Heart. 2022. PMID: 35110384. doi:10.1136/heartjnl-2021-320364
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。